ISRCTN33414972已完成未知
Mechanisms of action of hypoglycemic drugs in nonalcoholic fatty liver disease (NAFLD): elucidation of its association with 'inflammation'
niversity of Ryukyus (Japan)0 个研究点目标入组 800 人开始时间: 2013年12月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Diabetic males aged 40-70 years
- •2. Previously untreated for type 2 diabetes (T2DM)
- •3. Body mass index (BMI) >25 kg/m2
- •4. Glycated hemoglobin (HbA1c) of 6.4-7.9% (National Glycohemoglobin Standardization Program units)
- •5. Fasting plasma glucose of 126-261 mg/dl
排除标准
- •1. Patients with mental disorders, including alcohol dependence, or with such a history
- •2. Patients with pancreatitis
- •3. Patients with malignant diseases
- •4. Patients with viral hepatitis
- •5. Patients who have participated in any clinical study or trial within 6 months
- •6. Patients experiencing a weight gain or loss of 1 kg or more within 3 months before the start of the trial
- •7. Patients deemed ineligible for the trial
研究者
相似试验
招募中
不适用
Efficacy and safety of hypoglycemic agents in nonalcoholic fatty liver disease with type 2 diabetesJPRN-UMIN000045572ippon Medical School100
招募中
不适用
Study of effect of oral anti-diabetic medication on cognitive function in young and middle-aged type 2 diabetes mellitus patientsCTRI/2020/02/023645Dr Vangaveti Sneha
已完成
不适用
The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.Type 2 diabetesJPRN-UMIN000011793ational Center for Global Health and Medicine30
已完成
不适用
The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepirideonalcoholic fatty liver disease patients with type 2 diabetesJPRN-UMIN000021291Kawasaki Medical SchoolKawasaki Medical School Devision of Diabetes, Endocrinology and Metabolism90
招募中
3 期
A study of blood sugar reducing effect of Homoeopathic Drug Phosphoricum Acidum 6C under laboratory setting with clinical evaluation of the same in Type 2 Diabetes MellitusCTRI/2023/11/059774Dr Vineeth S Nair